ASTRAZENECA PLC (ZEG.DE) Stock Fundamental Analysis
FRA:ZEG - Deutsche Boerse Ag - GB0009895292 - Common Stock - Currency: EUR
ZEG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. While ZEG has a great profitability rating, there are some minor concerns on its financial health. ZEG has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ZEG had positive earnings in the past year.
In the past year ZEG had a positive cash flow from operations.
ZEG had positive earnings in each of the past 5 years.
Each year in the past 5 years ZEG had a positive operating cash flow.
1.2 Ratios
ZEG has a Return On Assets (6.17%) which is in line with its industry peers.
With a decent Return On Equity value of 16.30%, ZEG is doing good in the industry, outperforming 70.83% of the companies in the same industry.
ZEG has a better Return On Invested Capital (11.30%) than 68.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZEG is below the industry average of 12.45%.
The 3 year average ROIC (8.91%) for ZEG is below the current ROIC(11.30%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.17% | ||
| ROE | 16.3% | ||
| ROIC | 11.3% |
ROA(3y)3.13%
ROA(5y)3.27%
ROE(3y)8.13%
ROE(5y)11%
ROIC(3y)8.91%
ROIC(5y)8.48%
1.3 Margins
ZEG's Profit Margin of 13.11% is fine compared to the rest of the industry. ZEG outperforms 70.83% of its industry peers.
In the last couple of years the Profit Margin of ZEG has grown nicely.
ZEG's Operating Margin of 20.99% is fine compared to the rest of the industry. ZEG outperforms 62.50% of its industry peers.
ZEG's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 82.21%, ZEG belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
In the last couple of years the Gross Margin of ZEG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.99% | ||
| PM (TTM) | 13.11% | ||
| GM | 82.21% |
OM growth 3Y5.6%
OM growth 5Y12.05%
PM growth 3Y2.68%
PM growth 5Y5.91%
GM growth 3Y0.9%
GM growth 5Y0.4%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZEG is creating some value.
Compared to 1 year ago, ZEG has about the same amount of shares outstanding.
ZEG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ZEG has been reduced compared to a year ago.
2.2 Solvency
ZEG has an Altman-Z score of 4.77. This indicates that ZEG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ZEG (4.77) is better than 79.17% of its industry peers.
The Debt to FCF ratio of ZEG is 4.81, which is a neutral value as it means it would take ZEG, 4.81 years of fcf income to pay off all of its debts.
ZEG has a Debt to FCF ratio of 4.81. This is in the better half of the industry: ZEG outperforms 60.42% of its industry peers.
ZEG has a Debt/Equity ratio of 0.79. This is a neutral value indicating ZEG is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.79, ZEG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 4.81 | ||
| Altman-Z | 4.77 |
ROIC/WACC1.3
WACC8.68%
2.3 Liquidity
ZEG has a Current Ratio of 0.89. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.89, ZEG is doing worse than 89.58% of the companies in the same industry.
A Quick Ratio of 0.69 indicates that ZEG may have some problems paying its short term obligations.
ZEG has a worse Quick ratio (0.69) than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.89 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.43% over the past year.
Measured over the past years, ZEG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.95% on average per year.
Looking at the last year, ZEG shows a small growth in Revenue. The Revenue has grown by 3.29% in the last year.
The Revenue has been growing by 15.71% on average over the past years. This is quite good.
EPS 1Y (TTM)5.43%
EPS 3Y21.72%
EPS 5Y15.95%
EPS Q2Q%20.23%
Revenue 1Y (TTM)3.29%
Revenue growth 3Y19.84%
Revenue growth 5Y15.71%
Sales Q2Q%18.04%
3.2 Future
Based on estimates for the next years, ZEG will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.85% on average per year.
The Revenue is expected to grow by 7.94% on average over the next years.
EPS Next Y15.68%
EPS Next 2Y14.66%
EPS Next 3Y13.7%
EPS Next 5Y11.85%
Revenue Next Year15.89%
Revenue Next 2Y11.33%
Revenue Next 3Y9.45%
Revenue Next 5Y7.94%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.22, the valuation of ZEG can be described as rather expensive.
ZEG's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ZEG to the average of the S&P500 Index (28.47), we can say ZEG is valued slightly cheaper.
A Price/Forward Earnings ratio of 14.46 indicates a correct valuation of ZEG.
ZEG's Price/Forward Earnings is on the same level as the industry average.
ZEG is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.22 | ||
| Fwd PE | 14.46 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ZEG.
The rest of the industry has a similar Price/Free Cash Flow ratio as ZEG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.37 | ||
| EV/EBITDA | 29.17 |
4.3 Compensation for Growth
ZEG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ZEG has a very decent profitability rating, which may justify a higher PE ratio.
ZEG's earnings are expected to grow with 13.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)1.14
EPS Next 2Y14.66%
EPS Next 3Y13.7%
5. Dividend
5.1 Amount
ZEG has a Yearly Dividend Yield of 2.06%.
ZEG's Dividend Yield is a higher than the industry average which is at 2.69.
Compared to an average S&P500 Dividend Yield of 2.28, ZEG has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
5.2 History
The dividend of ZEG has a limited annual growth rate of 1.00%.
Dividend Growth(5Y)1%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
69.29% of the earnings are spent on dividend by ZEG. This is not a sustainable payout ratio.
ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP69.29%
EPS Next 2Y14.66%
EPS Next 3Y13.7%
ASTRAZENECA PLC
FRA:ZEG (2/4/2025, 7:00:00 PM)
133.4
-3.25 (-2.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.68%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap413.69B
Analysts80.59
Price Target160.53 (20.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
Yearly Dividend2.89
Dividend Growth(5Y)1%
DP69.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.5%
Min EPS beat(2)-1.9%
Max EPS beat(2)4.9%
EPS beat(4)2
Avg EPS beat(4)0.45%
Min EPS beat(4)-5%
Max EPS beat(4)4.9%
EPS beat(8)6
Avg EPS beat(8)3.48%
EPS beat(12)9
Avg EPS beat(12)2.73%
EPS beat(16)10
Avg EPS beat(16)1.04%
Revenue beat(2)1
Avg Revenue beat(2)1.87%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)4.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)4.27%
Revenue beat(8)2
Avg Revenue beat(8)-0.76%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.69%
PT rev (1m)-1.53%
PT rev (3m)-3.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.99%
EPS NY rev (1m)0.76%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)1.29%
Revenue NY rev (3m)1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.22 | ||
| Fwd PE | 14.46 | ||
| P/S | 8.7 | ||
| P/FCF | 61.37 | ||
| P/OCF | 38.64 | ||
| P/B | 10.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 29.17 |
EPS(TTM)7.32
EY5.49%
EPS(NY)9.22
Fwd EY6.91%
FCF(TTM)2.17
FCFY1.63%
OCF(TTM)3.45
OCFY2.59%
SpS15.33
BVpS12.33
TBVpS-6.54
PEG (NY)1.16
PEG (5Y)1.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.17% | ||
| ROE | 16.3% | ||
| ROCE | 13.61% | ||
| ROIC | 11.3% | ||
| ROICexc | 12.42% | ||
| ROICexgc | 79.12% | ||
| OM | 20.99% | ||
| PM (TTM) | 13.11% | ||
| GM | 82.21% | ||
| FCFM | 14.18% |
ROA(3y)3.13%
ROA(5y)3.27%
ROE(3y)8.13%
ROE(5y)11%
ROIC(3y)8.91%
ROIC(5y)8.48%
ROICexc(3y)9.75%
ROICexc(5y)9.57%
ROICexgc(3y)97.31%
ROICexgc(5y)84.98%
ROCE(3y)10.38%
ROCE(5y)9.87%
ROICexcg growth 3Y20.31%
ROICexcg growth 5Y22.06%
ROICexc growth 3Y6.49%
ROICexc growth 5Y16.91%
OM growth 3Y5.6%
OM growth 5Y12.05%
PM growth 3Y2.68%
PM growth 5Y5.91%
GM growth 3Y0.9%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 4.81 | ||
| Debt/EBITDA | 2.02 | ||
| Cap/Depr | 79.68% | ||
| Cap/Sales | 8.34% | ||
| Interest Coverage | 8.73 | ||
| Cash Conversion | 71.6% | ||
| Profit Quality | 108.18% | ||
| Current Ratio | 0.89 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 4.77 |
F-Score6
WACC8.68%
ROIC/WACC1.3
Cap/Depr(3y)50.25%
Cap/Depr(5y)59.78%
Cap/Sales(3y)6.64%
Cap/Sales(5y)7.96%
Profit Quality(3y)1230.07%
Profit Quality(5y)759.39%
High Growth Momentum
Growth
EPS 1Y (TTM)5.43%
EPS 3Y21.72%
EPS 5Y15.95%
EPS Q2Q%20.23%
EPS Next Y15.68%
EPS Next 2Y14.66%
EPS Next 3Y13.7%
EPS Next 5Y11.85%
Revenue 1Y (TTM)3.29%
Revenue growth 3Y19.84%
Revenue growth 5Y15.71%
Sales Q2Q%18.04%
Revenue Next Year15.89%
Revenue Next 2Y11.33%
Revenue Next 3Y9.45%
Revenue Next 5Y7.94%
EBIT growth 1Y13.56%
EBIT growth 3Y26.55%
EBIT growth 5Y29.65%
EBIT Next Year33.33%
EBIT Next 3Y17.92%
EBIT Next 5Y12.65%
FCF growth 1Y30.64%
FCF growth 3Y44.14%
FCF growth 5Y39.41%
OCF growth 1Y45.27%
OCF growth 3Y29.18%
OCF growth 5Y31.63%